New Zealand - English - Medsafe (Medicines Safety Authority)

a. menarini new zealand pty ltd - rosuvastatin calcium 10.4mg equivalent to rosuvastatin 10mg;   - film coated tablet - 10 mg - active: rosuvastatin calcium 10.4mg equivalent to rosuvastatin 10mg   excipient: calcium phosphate crospovidone hypromellose iron oxide red lactose monohydrate   magnesium stearate microcrystalline cellulose purified water titanium dioxide triacetin - crestor should be used as an adjunct to diet when the response to diet and exercise is inadequate. prevention of major cardiovascular events in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease, (see clinical efficacy) crestor is indicated to: reduce the risk of nonfatal myocardial infarction reduce the risk of nonfatal stroke reduce the risk of coronary artery revascularisation

New Zealand - English - Medsafe (Medicines Safety Authority)

a. menarini new zealand pty ltd - febuxostat 120mg;   - film coated tablet - 120 mg - active: febuxostat 120mg   excipient: colloidal silicon dioxide croscarmellose sodium hyprolose lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow 85f42129 - treatment of chronic hyperuricaemia in patients with gout (including a history, or presence of, tophus and/or gouty arthritis). adenuric is indicated in adults.

New Zealand - English - Medsafe (Medicines Safety Authority)

a. menarini new zealand pty ltd - febuxostat 80mg;   - film coated tablet - 80 mg - active: febuxostat 80mg   excipient: colloidal silicon dioxide croscarmellose sodium hyprolose lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow 85f42129 - treatment of chronic hyperuricaemia in patients with gout (including a history, or presence of, tophus and/or gouty arthritis). adenuric is indicated in adults.

New Zealand - English - Medsafe (Medicines Safety Authority)

a. menarini new zealand pty ltd - rosuvastatin calcium 20.8mg equivalent to rosuvastatin 20mg;   - film coated tablet - 20 mg - active: rosuvastatin calcium 20.8mg equivalent to rosuvastatin 20mg   excipient: calcium phosphate crospovidone hypromellose iron oxide red lactose monohydrate   magnesium stearate microcrystalline cellulose purified water titanium dioxide triacetin - crestor should be used as an adjunct to diet when the response to diet and exercise is inadequate. prevention of major cardiovascular events in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease, (see clinical efficacy) crestor is indicated to: reduce the risk of nonfatal myocardial infarction reduce the risk of nonfatal stroke reduce the risk of coronary artery revascularisation

New Zealand - English - Medsafe (Medicines Safety Authority)

a. menarini new zealand pty ltd - rosuvastatin calcium 41.6mg equivalent to rosuvastatin 40mg;   - film coated tablet - 40 mg - active: rosuvastatin calcium 41.6mg equivalent to rosuvastatin 40mg   excipient: calcium phosphate crospovidone hypromellose iron oxide red lactose monohydrate   magnesium stearate microcrystalline cellulose purified water titanium dioxide triacetin - crestor should be used as an adjunct to diet when the response to diet and exercise is inadequate. prevention of major cardiovascular events in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease, (see clinical efficacy) crestor is indicated to: reduce the risk of nonfatal myocardial infarction reduce the risk of nonfatal stroke reduce the risk of coronary artery revascularisation

New Zealand - English - Medsafe (Medicines Safety Authority)

a. menarini new zealand pty ltd - rosuvastatin calcium 5.2mg equivalent to rosuvastatin 5mg;   - film coated tablet - 5 mg - active: rosuvastatin calcium 5.2mg equivalent to rosuvastatin 5mg   excipient: calcium phosphate crospovidone hypromellose iron oxide yellow lactose monohydrate   magnesium stearate microcrystalline cellulose titanium dioxide triacetin - crestor should be used as an adjunct to diet when the response to diet and exercise is inadequate. prevention of major cardiovascular events in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease, (see clinical efficacy) crestor is indicated to: reduce the risk of nonfatal myocardial infarction reduce the risk of nonfatal stroke reduce the risk of coronary artery revascularisation

New Zealand - English - Medsafe (Medicines Safety Authority)

a. menarini new zealand pty ltd - dapoxetine hydrochloride 33.6mg equivalent to dapoxetine 30 mg;   - film coated tablet - 30 mg - active: dapoxetine hydrochloride 33.6mg equivalent to dapoxetine 30 mg   excipient: colloidal silicon dioxide croscarmellose sodium coating powder grey 4 lactose monohydrate as a spray-dried mixture of lactose monohydrate & microcrystalline cellulose magnesium stearate microcrystalline cellulose as a spray-dried mixture of lactose monohydrate & microcrystalline cellulose - priligy is indicated for the treatment of premature ejaculation (pe) in men 18 to 64 years of age, who have all of the following: · persistent or recurrent ejaculation with minimal sexual stimulation before, on, or shortly after penetration and before the patient wishes; and · marked personal distress or interpersonal difficulty as a consequence of pe; and · poor control over ejaculation.

New Zealand - English - Medsafe (Medicines Safety Authority)

a. menarini new zealand pty ltd - dapoxetine hydrochloride 67.2mg equivalent to dapoxetine 60 mg;   - film coated tablet - 60 mg - active: dapoxetine hydrochloride 67.2mg equivalent to dapoxetine 60 mg   excipient: colloidal silicon dioxide croscarmellose sodium coating powder grey 3 lactose monohydrate as a spray-ried mixture of lactose monohydrate & microcrystalline cellulose magnesium stearate microcrystalline cellulose as a spray-ried mixture of lactose monohydrate & microcrystalline cellulose - priligy is indicated for the treatment of premature ejaculation (pe) in men 18 to 64 years of age, who have all of the following: · persistent or recurrent ejaculation with minimal sexual stimulation before, on, or shortly after penetration and before the patient wishes; and · marked personal distress or interpersonal difficulty as a consequence of pe; and · poor control over ejaculation.

New Zealand - English - Medsafe (Medicines Safety Authority)

a. menarini new zealand pty ltd - benzatropine mesilate 1 mg/ml - solution for injection - 2 mg/2ml - active: benzatropine mesilate 1 mg/ml excipient: sodium chloride water for injection - cogentin is recommended for all forms of parkinsonism including arteriosclerotic, postencephalitic, idiopathic, as well as medicine-induced extrapyramidal disorders (except tardive dyskinesia). it can be effective at any stage of the disease, even when a patient has become bedridden. cogentin often is helpful in patients who have become unresponsive to other agents. cogentin is a powerful anticholinergic agent which is mainly effective in relieving tremor and rigidity. therapy is directed toward control of disturbing symptoms to permit the patient maximum integration of function with minimum discomfort. in non-medicine-induced parkinsonism, partial control of symptoms is usually achieved.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amitriptyline hydrochloride, quantity: 25 mg - tablet - excipient ingredients: maize starch; purified talc; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; quinoline yellow aluminium lake; lactose monohydrate; hypromellose; crospovidone; titanium dioxide; macrogol 6000 - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.